Cited by 26Heart Failure Treatment and ManagementCardiovascular and exercise physiologyHeart rate and cardiovascular health

The management of dyspnoea in chronic heart failure

Johnson, Miriam J, Oxberry, Stephen G·2010·Current Opinion in Supportive & Palliative Care

Abstract

PURPOSE OF REVIEW: To identify current management options for dyspnoeic people with chronic heart failure (CHF). RECENT FINDINGS: Research in people with CHF studying dyspnoea as a primary endpoint remains sparse. However, attention is turning towards symptoms as well as survival, and the need for agreed outcome measurement is recognized. There is relevant recent work examining both pharmacological and nonpharmacological interventions, targeting breathlessness directly or indirectly. There is evidence to support exercise training and mindfulness based programmes. The safety of morphine for breathlessness in acute heart failure has been retrospectively analysed but controlled clinical trials are required. Sildenafil may be useful for dyspnoea in CHF due to reduction of peripheral muscle signalling. Rolophylline, relaxin, carperitide, nesiritide and steroids warrant further evaluation. Bronchodilator use for dyspnoea in acute heart failure in the absence of COPD should be used with caution. A recent Cochrane review highlights the importance of diuretic therapy for both symptom control and optimizing prognosis. SUMMARY: Better standardization of dyspnoea outcome measures should help comparison of future trials. Optimization of diuretic therapy and attempted correction of neurohormonal disturbance in CHF remain the therapeutic targets for the underlying cause in dyspnoea management.

Integrity signals

Registry

Crossref · 10.1097/spc.0b013e32833929aa

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A greater focus on symptoms could enable promising alternative therapies such as relaxin and sildenafil to explore further, which have been yet to be formally approved due to unimproved mortality and hospitalization.

    “A greater focus on symptoms could enable promising alternative therapies such as relaxin and sildenafil to explore further which have been yet to be formally approved due to unimproved mortality and hospitalization. 60”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Johnson, M. J., & Oxberry, S. G.
Affiliations
Hull York Medical School (GB)
Corresponding author
Johnson, Miriam J
Venue
Current Opinion in Supportive & Palliative Care
Published
2010-06
Volume
4
Issue
2
Pages
63-68
ISSN
1751-4258 (ISSN-L)
OpenAlex
W1970933963
Cited by
26
References
37
Citations by year
2025: 1 · 2024: 1 · 2023: 1 · 2021: 1 · 2020: 3 · 2019: 2 · 2018: 1 · 2017: 2 · 2016: 1 · 2015: 1 · 2013: 2 · 2012: 1
FWCI
0.65
Type
journal article
Language
en
Open access
closed
Locations
  • Current Opinion in Supportive and Palliative Care (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
  • Health Sciences › Medicine › Complementary and alternative medicine › Cardiovascular and exercise physiology
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart rate and cardiovascular health
Keywords
dyspnea, chronic heart failure, breathlessness management, diuretic therapy, exercise training, mindfulness-based interventions, morphine, sildenafil, nesiritide, carperitide, relaxin, bronchodilators, neurohormonal activation, acute heart failure
MeSH terms
Contraindications, Bronchodilator Agents, Combined Modality Therapy, Diuretics, Dyspnea, Exercise Therapy, Heart Failure, Humans, Morphine, Narcotics, Vasodilator Agents, Mind-Body Therapies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review